Literature DB >> 20708155

Ink4a/Arf and oncogene-induced senescence prevent tumor progression during alternative colorectal tumorigenesis.

Moritz Bennecke1, Lydia Kriegl, Monther Bajbouj, Kristin Retzlaff, Sylvie Robine, Andreas Jung, Melek C Arkan, Thomas Kirchner, Florian R Greten.   

Abstract

Colonic cancers with a serrated morphology have been proposed to comprise a molecularly distinct tumor entity following an alternative pathway of genetic alterations independently of APC mutations. We demonstrate that intestinal epithelial cell specific expression of oncogenic K-ras(G12D) in mice induces serrated hyperplasia, which is characterized by p16(ink4a) overexpression and induction of senescence. Deletion of Ink4a/Arf in K-ras(G12D) expressing mice prevents senescence and leads to invasive, metastasizing carcinomas with morphological and molecular alterations comparable to human KRAS mutated serrated tumors. Thus, we suggest that oncogenic K-ras represents a key player during an alternative, serrated pathway to colorectal cancer and hence propose RAS-RAF-MEK signaling apart from APC as an additional gatekeeper in colorectal tumor development. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20708155     DOI: 10.1016/j.ccr.2010.06.013

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  92 in total

Review 1.  [Malignancy potential of precursor lesions: determination using molecular markers].

Authors:  A Jung
Journal:  Pathologe       Date:  2011-11       Impact factor: 1.011

Review 2.  [Prognostic marker profiles for risk of distant metastases in colorectal cancer].

Authors:  J Neumann; S Reu; T Kirchner
Journal:  Pathologe       Date:  2012-02       Impact factor: 1.011

Review 3.  The essence of senescence.

Authors:  Thomas Kuilman; Chrysiis Michaloglou; Wolter J Mooi; Daniel S Peeper
Journal:  Genes Dev       Date:  2010-11-15       Impact factor: 11.361

4.  Oncogenic KRas suppresses inflammation-associated senescence of pancreatic ductal cells.

Authors:  Kyoung Eun Lee; Dafna Bar-Sagi
Journal:  Cancer Cell       Date:  2010-11-16       Impact factor: 31.743

5.  A role for the epidermal growth factor receptor signaling in development of intestinal serrated polyps in mice and humans.

Authors:  Gerold Bongers; Luciana R Muniz; Michelle E Pacer; Alina C Iuga; Nanthakumar Thirunarayanan; Erik Slinger; Martine J Smit; E Premkumar Reddy; Lloyd Mayer; Glaucia C Furtado; Noam Harpaz; Sergio A Lira
Journal:  Gastroenterology       Date:  2012-05-26       Impact factor: 22.682

6.  KLF5 mediates the hyper-proliferative phenotype of the intestinal epithelium in mice with intestine-specific endogenous K-RasG12D expression.

Authors:  Mandayam O Nandan; Agnieszka B Bialkowska; Vincent W Yang
Journal:  Am J Cancer Res       Date:  2018-04-01       Impact factor: 6.166

7.  Mouse tissues that undergo neoplastic progression after K-Ras activation are distinguished by nuclear translocation of phospho-Erk1/2 and robust tumor suppressor responses.

Authors:  Neha Parikh; Ryan L Shuck; Thuy-Ai Nguyen; Alan Herron; Lawrence A Donehower
Journal:  Mol Cancer Res       Date:  2012-04-24       Impact factor: 5.852

Review 8.  Senescence at a glance.

Authors:  Jeff S Pawlikowski; Peter D Adams; David M Nelson
Journal:  J Cell Sci       Date:  2013-08-22       Impact factor: 5.285

9.  PPARγ-activation increases intestinal M1 macrophages and mitigates formation of serrated adenomas in mutant KRAS mice.

Authors:  Tobias Gutting; Christian A Weber; Philip Weidner; Frank Herweck; Sarah Henn; Teresa Friedrich; Shuiping Yin; Julia Kzhyshkowska; Timo Gaiser; Klaus-Peter Janssen; Wolfgang Reindl; Matthias P A Ebert; Elke Burgermeister
Journal:  Oncoimmunology       Date:  2018-02-01       Impact factor: 8.110

10.  Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions.

Authors:  Felipe De Sousa E Melo; Xin Wang; Marnix Jansen; Evelyn Fessler; Anne Trinh; Laura P M H de Rooij; Joan H de Jong; Onno J de Boer; Ronald van Leersum; Maarten F Bijlsma; Hans Rodermond; Maartje van der Heijden; Carel J M van Noesel; Jurriaan B Tuynman; Evelien Dekker; Florian Markowetz; Jan Paul Medema; Louis Vermeulen
Journal:  Nat Med       Date:  2013-04-14       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.